Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients

ClinicalTrials.gov ID: NCT01320202

Public ClinicalTrials.gov record NCT01320202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Phase III Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) in Chronic Kidney Disease Patients Receiving Hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE 1) Study

Study identification

NCT ID
NCT01320202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Rockwell Medical Technologies, Inc.
Industry
Enrollment
305 participants

Conditions and interventions

Interventions

  • Soluble Ferric Pyrophosphate (SFP) Drug
  • Standard dialysate Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Apr 30, 2013
Completion
Oct 31, 2013
Last update posted
Apr 25, 2017

2011 – 2013

United States locations

U.S. sites
45
U.S. states
16
U.S. cities
40
Facility City State ZIP Site status
Not listed Bakersfield California 93308
Investigative Site Chula Vista California 91910
Not listed Cudahy California 90201
Not listed Downey California 90240
Not listed Encino California 91316
Not listed Los Angeles California 90022
Not listed Los Angeles California 90033
Not listed Los Angeles California 90057
Not listed Los Angeles California 90404
Not listed National City California 91950
Not listed Northridge California 91324
Not listed Ontario California 91764
Not listed Panorama City California 91402
Not listed Riverside California 92505
Not listed San Dimas California 91773
Not listed Simi Valley California 93065
Not listed West Covina California 91792
Not listed Yuba City California 95991
Investigative Site Waterbury Connecticut 06708
Not listed Waterbury Connecticut 06708
Not listed Coral Springs Florida 33071
Not listed Miami Florida 33150
Investigative Site Augusta Georgia 30901
Not listed Chicago Illinois 60617
Not listed Michigan City Indiana 46360
Not listed Detroit Michigan 48202
Not listed Las Vegas Nevada 89102
Investigative Site Mineola New York 11501
Investigative Site Ridgewood New York 11385
Not listed Rosedale New York 11422
Not listed Yonkers New York 10704
Not listed Asheville North Carolina 28801
Not listed Durham North Carolina 27704
Not listed Winston-Salem North Carolina 27105
Not listed Cincinnati Ohio 45206
Not listed Toledo Ohio 43613
Not listed Sumter South Carolina 29150
Not listed Chattanooga Tennessee 37404
Not listed Arlington Texas 76011
Not listed Fort Worth Texas 76164
Investigative Site Houston Texas 77004
Not listed Houston Texas 77081
Not listed San Antonio Texas 78207
Not listed Fairfax Virginia 22030
Not listed Shorewood Wisconsin 53211

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01320202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01320202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →